Telix Symposium at EANM 2024

Does size matter in targeted radionuclide therapies?
Topics and speakers
Why size matters: The relative benefits of antibodies vs. small molecules in oncology - Prof. Arturo Chiti, IRCCS San Raffaele Hospital, Milan, Italy
When small may be smart: The role of small molecules in neuro-oncology - Prof. Nathalie Albert, Ludwig-Maximilian's-University of Munich, Munich, Germany
Where big may be best: The power of antibodies in onco-hematology - Prof. Stefano Fanti, University of Bologna, Bologna, Italy
How size will shape the future: The choice between antibodies and small molecules in uro-oncology - Prof. Karolien Goffin, University Hospital Leuven, Leuven, Belgium